ITAGLIPT VM
Category: Anti-diabetic Combination
Composition: Vildagliptin 50 mg + Metformin SR 500 mg

Overview
Dual oral therapy for Type 2 Diabetes Mellitus to improve glycemic control.

Mechanism of Action
Vildagliptin inhibits DPP-4; Metformin reduces hepatic glucose output and improves insulin sensitivity.

Key Clinical Uses
• Supports HbA1c reduction.
• Enhances insulin response.
• Sustained glycemic control.

Dosage Form : SR Tablet

Storage
Store below 30°C in a cool, dry place. Protect from moisture and keep out of reach of children.

Disclaimer
For use by registered medical practitioners only. Prescribe according to the approved prescribing information.